TheStreet lowered shares of Nu Skin Enterprises Inc. (NYSE:NUS) from a buy rating to a hold rating in a research note released on Monday.

Other analysts also recently issued research reports about the company. Citigroup Inc. upped their target price on Nu Skin Enterprises from $66.00 to $69.00 and gave the stock a buy rating in a research note on Wednesday, September 21st. Deutsche Bank AG upped their target price on Nu Skin Enterprises from $55.00 to $57.00 and gave the stock a buy rating in a research note on Friday, August 5th. Pivotal Research upped their target price on Nu Skin Enterprises from $60.00 to $70.00 and gave the stock a buy rating in a research note on Friday, August 5th. Zacks Investment Research downgraded Nu Skin Enterprises from a buy rating to a hold rating in a research note on Thursday, October 27th. Finally, Jefferies Group upped their target price on Nu Skin Enterprises from $53.00 to $61.00 and gave the stock a hold rating in a research note on Thursday, September 22nd. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of $56.25.

Nu Skin Enterprises (NYSE:NUS) opened at 52.18 on Monday. The firm’s 50-day moving average price is $58.29 and its 200 day moving average price is $53.67. Nu Skin Enterprises has a 12-month low of $23.51 and a 12-month high of $66.04. The stock has a market cap of $2.84 billion, a PE ratio of 21.11 and a beta of 1.75.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Thursday, November 3rd. The company reported $0.98 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.14. Nu Skin Enterprises had a return on equity of 20.06% and a net margin of 6.26%. The firm had revenue of $604 million for the quarter, compared to the consensus estimate of $583.74 million. During the same quarter in the prior year, the business earned $0.71 earnings per share. The company’s revenue was up 5.7% compared to the same quarter last year. Analysts anticipate that Nu Skin Enterprises will post $2.97 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another site, it was illegally stolen and republished in violation of US & international copyright legislation. The legal version of this piece can be read at https://www.thecerbatgem.com/2016/12/01/thestreet-lowers-nu-skin-enterprises-inc-nus-to-hold.html.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 7th. Investors of record on Friday, November 18th will be issued a $0.355 dividend. The ex-dividend date of this dividend is Wednesday, November 16th. This represents a $1.42 annualized dividend and a dividend yield of 2.72%. Nu Skin Enterprises’s dividend payout ratio is presently 57.96%.

In related news, Director Andrew D. Lipman sold 30,000 shares of the stock in a transaction that occurred on Thursday, September 22nd. The stock was sold at an average price of $64.13, for a total value of $1,923,900.00. Following the completion of the sale, the director now owns 36,090 shares of the company’s stock, valued at $2,314,451.70. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Chairman Steven Lund sold 61,000 shares of the stock in a transaction that occurred on Wednesday, October 26th. The shares were sold at an average price of $61.55, for a total value of $3,754,550.00. The disclosure for this sale can be found here. 4.60% of the stock is owned by corporate insiders.

Several large investors have recently bought and sold shares of the stock. The Manufacturers Life Insurance Company bought a new stake in Nu Skin Enterprises during the third quarter valued at approximately $106,000. Metropolitan Life Insurance Co. NY raised its position in shares of Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock valued at $109,000 after buying an additional 77 shares during the last quarter. Washington Trust Bank raised its position in shares of Nu Skin Enterprises by 0.6% in the third quarter. Washington Trust Bank now owns 2,011 shares of the company’s stock valued at $130,000 after buying an additional 11 shares during the last quarter. Solaris Asset Management LLC acquired a new position in shares of Nu Skin Enterprises during the third quarter valued at $138,000. Finally, Catalyst Capital Advisors LLC acquired a new position in shares of Nu Skin Enterprises during the third quarter valued at $143,000. 76.44% of the stock is owned by hedge funds and other institutional investors.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

5 Day Chart for NYSE:NUS

Receive News & Stock Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related stocks with our FREE daily email newsletter.